Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Nice recommends two blood tests to rule out pre-eclampsia in pregnant women

May 11, 2016 Medical Communications, Sales and Marketing NICE, Roche, regulation

The National Institute for Health and Care Excellence (Nice) has backed two blood tests to help rule-out a complication in …
News

Nice backs GSK’s lupus drug Benlysta

May 11, 2016 Research and Development, Sales and Marketing GSK, NHS, NICE, regulation

The National Institute for Health and Care Excellence (Nice) has backed GlaxoSmithKline’s (LSE: GSK) Benlysta (belimumab) to treat lupus.  The …
News

Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access

May 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi

Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …
News

Santen Pharmaceutical says eye allergy drug meets primary endpoints in Phase III trials

May 11, 2016 Research and Development, Sales and Marketing Eye Allergy, Santen Pharmaceutical, drug trial, phase III

Santen Pharmaceutical said late stage trials for its drug to treat an allergic eye condition in children met its primary …
News

Allergan to buy back $10 billion of stock, Q1 earnings rise

May 11, 2016 Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue

Botox-maker Allergan (NYSE: AGN) said it plans to buy back as much as $10 billion in stock after completing the …
News

FDA expands Imbruvica label with new survival data

May 11, 2016 Research and Development, Sales and Marketing AbbVie, FDA, Janssen, data, efficacy, expanded, imbruvica, label, late stage, phase III

The US Food and Drug Administration (FDA) has expanded the label of Imbruvica (ibrutinib) to include the data from recent …
News

Incyte acquires Ariad’s European operations in $140 million deal

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ariad, Incyte, Operations, buy out, european, iclusig, leukaemia, out-license

Incyte (NASDAQ: INCY) has entered into an agreement with Ariad Pharmaceuticals (NASDAQ: ARIA) that will see the company acquire Ariad’s …
News

Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing

UK-based Cell Therapy on Tuesday said it has signed a £12.5 million licensing deal with Japan’s Daiichi Sankyo (TYO: 4568) …
News

Medivation maybe mulling sale as bidding race heats up – Reports

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

Cancer drugmaker Medivation (Nasdaq: MDVN) is evaluating a potential sale following the recent string of offers from big pharma firms, …
News

China evaluating investigations into pharma firms to take on drug pricing issue

May 9, 2016 Business Services, Research and Development, Sales and Marketing China, France, G7, regulation

Lawmakers globally have acknowledged the concerns over unbridled drug costs as regulators stress the need for a more open debate …
News

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
News

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …
Feature

Chiesi set to acquire Medicine Co cardiovascular assets, say reports

May 9, 2016 Sales and Marketing Chiesi, assets, cardiovascular, medicine co

Italian pharmaceutical company Chiesi are set to expand their global footprint as it nears an agreement to acquire Medicines Co’s …
News

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016 Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …
News

BTG acquires promising oncology pipeline in Galil Medical takeover

May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026